https://www.selleckchem.com/pr....oducts/BMS-794833.ht
86; 95% confidence interval [CI], 0.72-0.94). We validated panel performance in an independent validation cohort (AUC, 0.82; 95% CI, 0.74-0.88). Our risk-stratification model was more accurate than the panel and an independent predictor for identification of LNM (AUC, 0.90; univariate odds ratio [OR], 37.17; 95% CI, 4.48-308.35; P .001; multivariate OR, 17.28; 95% CI, 1.82-164.07; P= .013). The model limited potential overtreatment to only 18% of all patients, which is dramatically superior to pathologic features that are curren
Like
Comment
Share
